Bone Biologics (BBLG) EPS (2014 - 2026)
Bone Biologics (BBLG) EPS from Mar 31, 2014 to Mar 31, 2026. The TTM Bone Biologics (BBLG) EPS is -$1.62. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Bone Biologics (BBLG) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -72.31% |
| 5 Years TTM | -8.89% |
Annual EPS change of Bone Biologics (BBLG)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.43 | -75.24% |
| 2025 | -$1.73 | -79.24% |
| 2024 | -$8.35 | -33.56% |
| 2023 | -$12.56 | +99.54% |
| 2021 | -$6.30 | -11.54% |
| 2020 | -$7.12 | +33.04% |
| 2019 | -$5.35 | -33.45% |
| 2018 | -$8.04 | -74.87% |
| 2016 | -$31.99 | +54.68% |
| 2015 | -$20.68 | +136.59% |
| 2014 | -$8.74 | +9006.25% |
| 2013 | -$0.10 | N/A |
| 2012 | -$0.10 | N/A |
Comparison Bone Biologics (BBLG) five years EPS CAGR with competitors
Bone Biologics (BBLG) five years EPS CAGR is -27.24%.